Optometry Education and CME

Select a Specialty

DR
CME

Assessing and Treating Diabetic Retinopathy Amid New Recommendations and Evidence

This activity is supported by an educational grant from Genentech, Inc.

Expiration Date: 6/10/2019
Credit Type(s): CME | Credit: 1.25

Although rapid advances have been made in the treatment of diabetic macular edema (DME), particularly with the use of intravitreal therapy, options for the management of…

go to activity»
Proliferative and Non-proliferative Diabetic Retinopathy: Weighing the Evidence for Medical Treatment
CME

Proliferative and Nonproliferative Diabetic Retinopathy: Weighing the Evidence for Medical Treatment

This activity is supported by an educational grant from Genentech, Inc.

Expiration Date: 4/26/2019
Credit Type(s): CME | Credit: 0.5

Although rapid advances have been made in the treatment of diabetic macular edema (DME), particularly with the use of intravitreal therapy, options for the management of…

go to activity»
Macular Degeneration CME
CME

Advancing Science on Age-related Macular Degeneration

This activity is supported by an educational grant from Genentech, Inc.

Expiration Date: 3/25/2019
Credit Type(s): CME | Credit: 1.25

Age-related macular degeneration (AMD) is one of the leading causes of adult blindness and visual impairment. Because age is a major risk factor for developing AMD, it…

go to activity»
J894
CME

Improving the Clinical Picture of IOP in Glaucoma Through Innovative Treatments

This activity is supported by an educational grant from Bausch + Lomb.

Expiration Date: 4/8/2019
Credit Type(s): CME | Credit: 0.75

Glaucoma is the leading cause of irreversible blindness worldwide, with an estimated 70 million people currently affected by the condition. Advances in imaging have…

go to activity»
J554_02
CME

MIGS Perspectives with Reay H. Brown, MD

This activity is supported by educational grants from Aerie Pharmaceuticals, Inc.; Alcon Laboratories, Inc.; Bausch + Lomb; Glaukos Corporation; and Novartis Pharmaceuticals Corporation.

Expiration Date: 3/19/2019
Credit Type(s): CME | Credit: 0.25

Minimally invasive glaucoma surgery (MIGS) is generally safer, with quicker recovery times. This on-the-scene expert interview will describe new advances with MIGS for…

go to activity»
Genetic Testing for Inherited Retinal Diseases in Ophthalmology: What Do Clinicians Need to Know?

The landscape of genetic testing and treatment for inherited retinal diseases (IRDs) is rapidly evolving. Keeping up-to-date on clinical trials, ordering and…

go to activity»
Reducing IOP and Improving Compliance in 2018: New Opportunities in Medical Glaucoma Treatment
CME

Reducing IOP and Improving Compliance in 2018: New Opportunities in Medical Glaucoma Treatment

This activity is supported by an educational grant from Aerie Pharmaceuticals, Inc.

Expiration Date: 5/25/2019
Credit Type(s): CME | Credit: 1.25

Glaucoma is the leading cause of irreversible blindness worldwide, with an estimated 70 million people currently affected by the condition. Advances in imaging have…

go to activity»
Ocular Surface
CME

Preserving the Ocular Surface: Practice Pearls Part 3

This activity is supported by educational grants from Allergan, Inc.; Bausch + Lomb; and Shire.

Expiration Date: 4/23/2019
Credit Type(s): CME | Credit: 0.5

Dry eye symptoms are experienced by many patients, especially with aging. Unfortunately, millions of patients with ocular surface disease are underdiagnosed in the…

go to activity»
J970
CME

Assessing and Treating Diabetic Retinopathy Amid New Recommendations and Evidence

This activity is supported by an educational grant from Genentech, Inc.

Expiration Date: 4/9/2019
Credit Type(s): CME | Credit: 0.75

Although rapid advances have been made in the treatment of diabetic macular edema (DME), particularly with the use of intravitreal therapy, options for the management of…

go to activity»
Dry Eye
CME

Treating Inflammation in Dry Eye: The Rule, Not the Exception

This activity is supported by an educational grant from Allergan, Inc.

Expiration Date: 4/3/2019
Credit Type(s): CME | Credit: 0.75

Dry eye disease (DED) is one of the most frequently encountered ocular surface disorders. It is a growing public health problem and one of the most common conditions…

go to activity»
cypass stent
CME

Case Presentation: CyPass Stent in the Left Eye and an iStent in the Right Eye

This activity is supported by educational grants from Aerie Pharmaceuticals, Inc.; Alcon Laboratories, Inc.; Bausch + Lomb; Glaukos Corporation; and Novartis Pharmaceuticals Corporation.

Expiration Date: 1/5/2019
Credit Type(s): CME | Credit: 0.25

In this CME activity, the clinical course of a patient with a CyPass Stent in the left eye and an iStent in the right eye will be described….

go to activity»
J554-HEA003
CME

Medical Management of Glaucoma: Recent Approvals and Drugs Under Investigation

This activity is supported by educational grants from Aerie Pharmaceuticals, Inc.; Alcon Laboratories, Inc.; Bausch + Lomb; Glaukos Corporation; and Novartis Pharmaceuticals Corporation.

Expiration Date: 12/19/2018
Credit Type(s): CME | Credit: 0.5

Glaucoma is the leading cause of irreversible blindness worldwide, with an estimated 70 million people affected by the condition. This activity will evaluate clinical…

go to activity»